Navigation Links
Sun burns treated with creams

Researchers observe that a new topical medication can effectively treat signs of aging due to repeated exposure to the sun. They found that in a long-term study of tazarotene cream, has successfully reduced fine wrinkling and mottled skin in more than 55 percent// of those tested, and it continued to show additional benefit as the length of use increased.

Ultraviolet radiation from the sun is known to have numerous ill effects on the skin, leading not only to the typical signs of aging, but also to skin cancer. Tazarotene has been shown in several studies to reduce these effects, but none have tested the treatment for longer than six months. These researchers measured the safety and effectiveness of the cream in a 25-week study, which was followed by an additional 26-week period in which participants were allowed to continue using the cream while being followed by the researchers.

In the first study period, about 573 subjects were assigned to receive either 0.15 percent tazarotene cream or treatment with a placebo cream for comparison purposes. All applied the creams on their faces once a day. Researchers then assessed each for various measures related to skin health. About 25 subjects in the tazarotene group dropped out due to skin irritation, compared to one in the placebo group. Blood levels of the medication, however, remained in the acceptable range.

After the initial 25-week period, all participants were offered the active treatment, and as of the one-year follow-up, the beneficial effects of the cream had yet to level off in the subjects. The authors write, "Efficacy was further improved with continued treatment and had not plateaued after 14 months, suggesting that additional efficacy may be achievable with longer-term treatment."


'"/>




Page: 1

Related medicine news :

1. Eating wrong foods may cause heartburns at night
2. Nervous disorder being treated
3. Acoustic neuroma in older patients to be treated
4. Rectal Cancer treated with radiation
5. Benign eye tumors being treated
6. Back pain treated with Opioids
7. Heart disease in women being under-treated
8. Adult COPD or asthma could be effectively treated with Xopenex
9. Resistant tumors could be treated with the discovery of a new molecule within cancer cells
10. Untreated Scoliosis patients found to lead productive and active lives
11. Cardiac events better treated with intense cholesterol-lowering regime
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:7/21/2017)... ... July 21, 2017 , ... ... students improve their chances of acceptance to a residency in a United States ... earned degrees outside the U.S. , According to data released by the ECFMG®, ...
(Date:7/21/2017)... ... July 21, 2017 , ... West Dermatology is pleased ... Vu, PA-C. Beginning July 17, 2017, Ms. Vu will join West Dermatology’s large network ... experience in dermatology, skin cancer , and more. She graduated from the University ...
(Date:7/21/2017)... ... July 21, 2017 , ... How physicians and ... the rise, say researchers presenting their work at the American Orthopaedic Society ... combination of evaluating the patterns of change in concussion symptom presentation, diagnostic tools ...
(Date:7/20/2017)... ... July 20, 2017 , ... Acute myeloid leukemia (AML) is ... rapidly without treatment. Newly diagnosed patients face intense chemotherapy regimens and a stem ... With such a challenging diagnosis that requires immediate action, patients and caregivers ...
(Date:7/20/2017)... ... ... For individuals with extended hospital stays or who are residents of nursing ... specially designed to accommodate patients with a wide range of ailments or special needs, ... has invented the patent-pending PORTABLE ARM REST, a specially designed armrest that features many ...
Breaking Medicine News(10 mins):
(Date:7/12/2017)... and Company (NYSE: LLY ) has entered into ... litigation in the U.S. District Court for the Eastern District ... (tadalafil) unit dose patent. This patent was previously set ... agreement, Cialis exclusivity is now expected to end at the ... patent for Cialis is valid and infringed by companies seeking ...
(Date:7/11/2017)... 11, 2017  The global market for liquid biopsy ... $394.1 million in 2016.  Although in early stages, the ... in particular as a result of the gradual shift ... recent introduction of a significant number of new liquid ... of tumor biomarkers to guide treatment decisions. ...
(Date:7/11/2017)... July 11, 2017 Oramed Pharmaceuticals Inc. (NASDAQ: ... pharmaceutical company focused on the development of oral drug ... Drug Administration (FDA) has agreed to schedule an End-of-Phase ... IIb trial of its oral insulin capsule ORMD-0801 in ... trial met primary and secondary endpoints by indicating a ...
Breaking Medicine Technology: